Skip to content

In vivo bioequivalence study of a new clobetasol propionate 0.05% topical cream compared to DERMOVAL® 0.05% cream using the skin blanching bioassay in healthy subjects.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504879-24-00
Enrollment
102
Registered
2023-10-30
Start date
2023-12-12
Completion date
2024-07-25
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

corticosteroid-sensitive dermatosis

Interventions

None listed

Sponsors

Substipharm
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026